ICD-10 Coding for Fibroma(C43.0U, D21.9, D21.9B)
Explore detailed ICD-10 coding guidelines for fibromas, including uterine fibroids and dermatofibromas. Learn about documentation requirements and coding pitfalls.
Complete code families applicable to Fibroma
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| D25.0 | Submucous leiomyoma of uterus | Use when a submucosal fibroid is confirmed by imaging. |
|
| D21.9 | Benign neoplasm of connective and other soft tissue, unspecified | Use when a fibroma is identified in soft tissue without a specific site. |
|
| D22.0 | Melanocytic nevi of lip | Use for dermatofibromas confirmed by biopsy on the lip. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutFibroma
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Fibroma.
Vague documentation of fibroma location.
Impact
Clinical: May lead to inappropriate treatment decisions., Regulatory: Increases risk of audit., Financial: Potential for claim denials.
Mitigation
Use specific anatomical terms in documentation., Verify imaging or pathology reports before coding.
Using unspecified codes when specific codes are available.
Impact
Reimbursement: May lead to claim denials or reduced reimbursement., Compliance: Increases risk of audit due to lack of specificity., Data Quality: Decreases accuracy of health records.
Mitigation
Ensure imaging or biopsy confirms the specific type and location of fibroma.
Use of unspecified codes
Impact
High risk of audit if unspecified codes are used when specific codes are available.
Mitigation
Ensure all fibroma diagnoses are supported by specific imaging or biopsy results.